Breaking News, Promotions & Moves

4basebio Appoints Chief Commercial Officer

Gabe Longoria joins 4basebio following a successful tenure as Chief Commercial Officer at Astrea Bioseparations Ltd.

Author Image

By: Charlie Sternberg

Associate Editor

Gabe Longoria.

4basebio PLC, a company that develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, has appointed Gabe Longoria as Chief Commercial Officer. The appointment follows the completion of the Company’s £40 million investment announced on November 12, 2024, which marked a key milestone in its journey to deliver scalable, high-quality synthetic DNA solutions to the global market, addressing critical needs in the gene therapy and mRNA vacc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics